Omeros (OMER) Accumulated Depreciation (2011 - 2026)
Omeros (OMER) reported Accumulated Depreciation of $12.3 million for Q1 2026, up 8.05% on a YoY basis from $11.4 million in Q1 2025, and up 1.99% sequentially from $12.0 million in Q4 2025.
Omeros (OMER) Accumulated Depreciation (2011 - 2026) Analysis & Trends
Omeros (OMER) has 11 years of Accumulated Depreciation data on file, last reported at $12.3 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation rose 8.05% year-over-year to $12.3 million; the trailing twelve-month figure through Mar 2026 stood at $12.3 million (up 8.05% YoY), and the FY2025 full-year result was $12.0 million, up 8.71% from the prior year.
- Accumulated Depreciation improved to $12.3 million in Q1 2026, from $12.0 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $12.3 million in Q1 2026 to a low of $9.3 million in Q1 2022.
- A 5-year average of $10.6 million and a median of $10.4 million in 2024 frame the typical range for Accumulated Depreciation.
- Across the five-year window, Accumulated Depreciation climbed 15.85% in 2022 and rose 2.11% in 2023, its largest moves.
- Tracing OMER's Accumulated Depreciation over 5 years: stood at $9.5 million in 2022, then rose by 7.26% to $10.2 million in 2023, then climbed by 8.11% to $11.1 million in 2024, then increased by 8.71% to $12.0 million in 2025, then grew by 1.99% to $12.3 million in 2026.
- Business Quant data shows OMER's Accumulated Depreciation at $12.3 million in Q1 2026, $12.0 million in Q4 2025, and $11.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.28 Mn |
| Dec 31, 2025 | 12.04 Mn |
| Sep 30, 2025 | 11.80 Mn |
| Jun 30, 2025 | 11.55 Mn |
| Mar 31, 2025 | 11.36 Mn |
| Dec 31, 2024 | 11.07 Mn |
| Sep 30, 2024 | 10.77 Mn |
| Jun 30, 2024 | 10.54 Mn |
| Mar 31, 2024 | 10.45 Mn |
| Dec 31, 2023 | 10.24 Mn |
| Sep 30, 2023 | 10.04 Mn |
| Jun 30, 2023 | 9.84 Mn |
| Mar 31, 2023 | 9.51 Mn |
| Dec 31, 2022 | 9.55 Mn |
| Sep 30, 2022 | 9.76 Mn |
| Jun 30, 2022 | 9.44 Mn |
| Mar 31, 2022 | 9.31 Mn |
| Dec 31, 2021 | 9.03 Mn |
| Sep 30, 2021 | 8.71 Mn |
| Jun 30, 2021 | 8.39 Mn |